Mark Holodniy researcher
Holodniy, Mark
VIAF ID: 287163734 (Personal)
Permalink: http://viaf.org/viaf/287163734
Preferred Forms
-
-
- 100 0 _ ‡a Mark Holodniy ‡c researcher
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease. | |
Healthcare-associated Legionnaires' disease: Limitations of surveillance definitions and importance of epidemiologic investigation. | |
High levels of adherence do not prevent accumulation of HIV drug resistance mutations | |
HIV-1 load quantitation: a 17-year perspective | |
HIV-1 Protease, Reverse Transcriptase, and Integrase Variation | |
HIV-1 RNA and viral load | |
HIV–HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance | |
HIV infection in the elderly. | |
HIV quantitation in spiked vaginocervical secretions: lack of non-specific inhibitory factors. DATRI 005 Study Team. Division of AIDS Treatment Research Initiative. | |
HIV testing of at risk patients in a large integrated health care system | |
HIV viral load markers in clinical practice | |
Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients | |
Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients | |
Incidence, etiology, and severity of acute gastroenteritis among prospectively enrolled patients in 4 Veterans Affairs hospitals and outpatient centers, 2016-18 | |
Infectious complications in OIF/OEF veterans with traumatic brain injury | |
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4 | |
Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial | |
Is spinal tuberculosis contagious? | |
A joint frailty model provides for risk stratification of HIV-infected patients based on unobserved heterogeneity. | |
Localized Cluster Detection Applied to Joint and Separate Military and Veteran Subpopulations | |
Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV | |
Maternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaques | |
Meeting Mandatory Infectious Disease Reporting Requirements: The Department of Veterans Affairs’ Plan. | |
A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants. | |
MicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature | |
Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA) | |
Multifunctional coatings to simultaneously promote osseointegration and prevent infection of orthopaedic implants | |
Novel targets for antiretroviral therapy: clinical progress to date | |
The OPTIMA Cohort | |
Oseltamivir for treatment and prophylaxis of influenza infection | |
Outcomes associated with a cognitive-behavioral chronic pain management program implemented in three public HIV primary care clinics | |
Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study | |
Pharmacokinetics and tolerability of oseltamivir combined with probenecid. | |
Phylogeny of Zika Virus in Western Hemisphere, 2015 | |
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment | |
Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients. | |
Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative study | |
Prevention of shingles by varicella zoster virus vaccination | |
Proteomic analysis of serum cytokine levels in response to highly active antiretroviral therapy (HAART). | |
Public health practice is not research | |
Public health surveillance in the U.S. Department of Veterans Affairs: evaluation of the Praedico surveillance system | |
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events | |
Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection | |
Quantitative virological measures of antiretroviral therapy | |
Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning | |
Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials | |
Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction | |
Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004). | |
The Relationship Between HIV Infection and Cardiovascular Disease | |
Reply to Young et al. | |
Representational fluency in HIV clinical practice: a model of instructor discourse | |
Results from a large-scale epidemiologic look-back investigation of improperly reprocessed endoscopy equipment | |
Reuse of insulin pens among multiple patients at 2 Veterans Affairs medical centers | |
A review of drug-drug interactions in older HIV-infected patients | |
Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020 | |
Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population | |
Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations | |
Safety of zoster vaccine in elderly adults following documented herpes zoster | |
Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy | |
Severe pneumonia due to adenovirus serotype 14: a new respiratory threat? | |
siRNA Delivery into Human T Cells and Primary Cells with Carbon-Nanotube Transporters | |
Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysis | |
Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds | |
Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review | |
Sudden sensorineural hearing loss associated with vardenafil | |
The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia | |
A systematic review of cost-utility analyses in HIV/AIDS: implications for public policy | |
Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature. | |
Trends in Incidence of Norovirus-associated Acute Gastroenteritis in Four Veterans Affairs Medical Center Populations in the United States, 2011-2015 | |
Ultrasensitive detection of rare mutations using next-generation targeted resequencing | |
Use of dried clinical samples for storing and detecting influenza RNA. | |
Utilization and access to antiretroviral genotypic resistance testing and results within the US Department of Veterans Affairs | |
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults | |
The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study | |
Validation of Acute Gastroenteritis-related International Classification of Diseases, Clinical Modification Codes in Pediatric and Adult US Populations | |
Zika virus infection in the Veterans Health Administration (VHA), 2015-2016. |